{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:42:46Z","timestamp":1788982966378,"version":"build-2803163510"},"reference-count":75,"publisher":"Informa UK Limited","issue":"1","funder":[{"name":"The authors have no funding to report"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/14712598.2021.1942832","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T23:03:41Z","timestamp":1623711821000},"page":"79-85","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Interleukin-6 inhibition: a therapeutic strategy for the management of adult-onset Still\u2019s disease"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2646-5765","authenticated-orcid":false,"given":"Yuko","family":"Kaneko","sequence":"first","affiliation":[{"name":"Keio University School of Medicine","place":["Shinjuku-ku, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Keio University School of Medicine","place":["Shinjuku-ku, Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0081-x"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.30.2.121"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8561-9"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.971052"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.058"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213920"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0569-6"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.973659"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.7.587"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.2188\/jea.7.221"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2014.974881"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.7.587"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/03009740510026616"},{"key":"e_1_3_4_15_1","first-page":"1","article-title":"Clinical features of elderly-onset adult-onset Still\u2019s disease","volume":"13","author":"Maruyama A","year":"2020","unstructured":"Maruyama A, Kokuzawa A, Yamauchi Y, et al. Clinical features of elderly-onset adult-onset Still\u2019s disease. Mod Rheumatol. 2020;13:1\u20137.","journal-title":"Mod Rheumatol"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199103000-00004"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1930"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4239"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2629"},{"issue":"5","key":"e_1_3_4_20_1","first-page":"665","article-title":"Adult Still\u2019 s disease-recognition of a clinical syndrome and recent experience","volume":"142","author":"Larson EB","year":"1985","unstructured":"Larson EB. Adult Still\u2019 s disease-recognition of a clinical syndrome and recent experience. West J Med. 1985;142(5):665\u2013671.","journal-title":"West J Med"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.042143"},{"issue":"6","key":"e_1_3_4_22_1","article-title":"Adult-onset Still\u2019s disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse","volume":"37","author":"Takakuwa Y","year":"2019","unstructured":"Takakuwa Y, Hanaoka H, Kiyokawa T, et al. Adult-onset Still\u2019s disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse. Clin Exp Rheumatol. 2019;37(6):23\u201327. Suppl.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000188009.47085.76"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2010.00707.x"},{"issue":"3","key":"e_1_3_4_25_1","first-page":"424","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi M","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19(3):424\u2013430.","journal-title":"J Rheumatol"},{"issue":"2","key":"e_1_3_4_26_1","first-page":"322","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease","volume":"28","author":"Fautrel B","year":"2001","unstructured":"Fautrel B, Le Mo\u00ebl G, Saint-Marcoux B, et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease. J Rheumatol. 2001;28(2):322\u2013329.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1137-7"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.07.005"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.07.018"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.12.1398"},{"key":"e_1_3_4_31_1","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease","volume":"31","author":"Chen DY","year":"2004","unstructured":"Chen DY, Lan JL, Lin FJ, et al. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still\u2019s disease. JRheumatol. 2004;31:2189\u20132198.","journal-title":"JRheumatol"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22194"},{"issue":"11","key":"e_1_3_4_33_1","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still\u2019s disease","volume":"30","author":"Choi JH","year":"2003","unstructured":"Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still\u2019s disease. J Rheumatol. 2003;30(11):2422\u20132427.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4812"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4193"},{"key":"e_1_3_4_36_1","first-page":"156","article-title":"Neutrophil CD64 is upregulated in patients with active adult-onset Still\u2019s disease, Scand","volume":"41","author":"Komiya A","year":"2012","unstructured":"Komiya A, Matsui T, Nogi S, et al. Neutrophil CD64 is upregulated in patients with active adult-onset Still\u2019s disease, Scand. J Rheumatol. 2012;41:156\u2013158.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161354"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34514"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1800-z"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-0138-5"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100247"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050473"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016428"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.111.4.1194"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0419-z"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60454-7"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112802"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202310"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.844404"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38984"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1631-y"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20319"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-013-2381-5"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.05.003"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13639-y"},{"issue":"3","key":"e_1_3_4_56_1","first-page":"e13936","article-title":"Adult-onset still\u2019s disease and treatment results with tocilizumab","volume":"75","author":"K\u0131r S","year":"2020","unstructured":"K\u0131r S, \u00d6zgen M, Zontul S. Adult-onset still\u2019s disease and treatment results with tocilizumab. Int J Clin Pract. 2020;75(3):e13936.","journal-title":"Int J Clin Pract"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000007596"},{"key":"e_1_3_4_58_1","first-page":"1","article-title":"Effectiveness of subcutaneous tocilizumab in refractory adult Still\u2019s disease: report of three cases and a review of the literature","volume":"9","author":"Torigoe M","year":"2021","unstructured":"Torigoe M, Maeshima K, Kuriyama Y, et al. Effectiveness of subcutaneous tocilizumab in refractory adult Still\u2019s disease: report of three cases and a review of the literature. Mod Rheumatol Case Rep. 2021;9:1\u201311.","journal-title":"Mod Rheumatol Case Rep"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04622-4"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22110"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2018.1533514"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez154"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216699"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001246"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev382"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04456-9"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140288"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207818"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13554-012-0001-6"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-020-0399-1"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2020.1818961"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2020.1741073"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20974858"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.85.5.421"},{"issue":"5","key":"e_1_3_4_75_1","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens EM","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, et al. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34(5):1133\u20131138.","journal-title":"J Rheumatol"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100996"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2021.1942832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T19:06:03Z","timestamp":1770404763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2021.1942832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/14712598.2021.1942832"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2021.1942832","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}